Huateng Pharma Scheduled to Attend CPHI Barcelona 2023

Huateng Pharma is gearing up to make its presence felt at CPhI Barcelona, the world's premier exhibition for global pharmaceutical ingredients, fine chemicals, and excipients, set to unfold in Barcelona from October 24th to 26th, 2023.

Located at Booth 3C02, Hall 3, Huateng Pharma, renowned as a world-leading supplier of PEG derivatives and a Contract Development and Manufacturing Organization (CDMO) for APIs and intermediates across the spectrum from R&D lab supply to commercial production, is all set to engage the pharmaceutical industry in stimulating conversations.

With cutting-edge PEGs technology, Huateng Pharma provides comprehensive support to the bio-pharmaceutical sector. Additionally, the company offers tailor-made raw materials solutions for the chemical pharmaceutical industry through its state-of-the-art CDMO capabilities.

The marketing director of Huateng Pharma expressed the significance of CPhI Barcelona, stating, "CPhI Barcelona is one of the largest events in the pharmaceutical calendar. We are looking forward to connecting with like-minded individuals and discussing how we can accelerate medicines development together."

Huateng Pharma will be showcasing its featured products at CPhI Barcelona:

1. PEG derivatives: These include both monodispersed and polydispersed PEG derivatives, which find applications in ADCs, PROTACs, LNP drug delivery, medical devices, and more.
2. Cholesterol (Plant-Derived): Beyond serving as pharmaceutical excipients, cholesterol is a crucial ingredient for high-end cosmetics and serves as a starting material for the synthesis of vitamin D3. It also plays a pivotal role in the synthesis of various osteopontanol series of APIs and feed additives.
3. Pharmaceutical intermediates: Huateng Pharma offers a wide array of pharmaceutical intermediates, including those for antidiabetic drugs (such as canagliflozin intermediates, dapagliflozin intermediates, empagliflozin intermediates, and semaglutide intermediates), antineoplastic drugs (including carfilzomib intermediates and palbociclib intermediates), and other API intermediates (such as edoxaban intermediates, fexuprazan intermediates, tafamidis intermediates, voxelotor intermediates), among others.

If you're keen to connect with Huateng Pharma at CPhI, don't hesitate to reach out now to schedule a meeting. Our team eagerly awaits your visit at Booth 3C02, Hall 3.